5-hydroxymethylcytosine has been researched along with Atheroma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, G; Duan, Q; Gao, L; Hu, C; Jiang, D; Lu, K; Sun, M; Tao, H; Wang, Y; Wu, S; You, L; Zhang, D | 1 |
Jiang, ZS; Li, AF; Li, GH; Li, RQ; Liu, LS; Peng, J; Ren, Z; Tang, XQ; Tang, ZH; Wang, Z; Wei, DH; Yang, Q; Zheng, XL | 1 |
1 trial(s) available for 5-hydroxymethylcytosine and Atheroma
Article | Year |
---|---|
DNA hydroxymethylation combined with carotid plaques as a novel biomarker for coronary atherosclerosis.
Topics: 5-Methylcytosine; Aged; Biomarkers; Carotid Intima-Media Thickness; Case-Control Studies; Coronary Artery Disease; DNA Methylation; Female; Humans; Leukocytes, Mononuclear; Male; Plaque, Atherosclerotic | 2019 |
1 other study(ies) available for 5-hydroxymethylcytosine and Atheroma
Article | Year |
---|---|
Tet methylcytosine dioxygenase 2 inhibits atherosclerosis via upregulation of autophagy in ApoE-/- mice.
Topics: 5-Methylcytosine; Animals; Apolipoproteins E; Atherosclerosis; Autophagy; Cytokines; Dioxygenases; Disease Models, Animal; DNA Methylation; DNA-Binding Proteins; Gene Expression; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Immunohistochemistry; Inflammation Mediators; Lipoproteins, LDL; Male; Mice; Mice, Knockout; Plaque, Atherosclerotic; Proto-Oncogene Proteins | 2016 |